Roger Henriksson

24.1k total citations · 5 hit papers
405 papers, 14.7k citations indexed

About

Roger Henriksson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roger Henriksson has authored 405 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 111 papers in Oncology and 98 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roger Henriksson's work include Glioma Diagnosis and Treatment (93 papers), Brain Metastases and Treatment (39 papers) and Neuropeptides and Animal Physiology (29 papers). Roger Henriksson is often cited by papers focused on Glioma Diagnosis and Treatment (93 papers), Brain Metastases and Treatment (39 papers) and Neuropeptides and Animal Physiology (29 papers). Roger Henriksson collaborates with scholars based in Sweden, United States and United Kingdom. Roger Henriksson's co-authors include Kjell Grankvist, Lars Franzén, Wolfgang Wick, Håkan Hedman, Björn Tavelin, Olivier Chinot, A. Tommy Bergenheim, Ryo Nishikawa, Frank Saran and Warren Mason and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Roger Henriksson

400 papers receiving 14.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

2014 1.8k citations Olivier Chinot, Wolfgang Wick et al. profile →
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

2012 866 citations Annika Malmström, Roger Stupp et al. profile →
EANO guidelines for the diagnosis and treatment of meningiomas

2016 571 citations Roger Henriksson et al. profile →
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

2014 568 citations Roger Stupp, Roger Henriksson et al. profile →
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

2017 426 citations Roger Henriksson, Wolfgang Wick et al. profile →

Peers

Countries citing papers authored by Roger Henriksson

Since Specialization

Citations

This map shows the geographic impact of Roger Henriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Henriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Henriksson more than expected).

Fields of papers citing papers by Roger Henriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Henriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Henriksson. The network helps show where Roger Henriksson may publish in the future.

Co-authorship network of co-authors of Roger Henriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Henriksson. A scholar is included among the top collaborators of Roger Henriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Henriksson. Roger Henriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis – results from the population-based Fex-Can Cohort study 2023 ·Acta Oncologica ·Kenny A. Rodriguez‐Wallberg, Johan Ahlgren, Karin E. Smedby, Jessica R. Gorman, Kristina Hellman, Roger Henriksson, Olof Ståhl, Lena Wettergren, Claudia Lampic	9
2	OS13.7.A ONSET SYMPTOMS PREDICT SURVIVAL IN GLIOBLASTOMA PATIENTS -REAL WORLD DATA FROM 1719 PATIENTS IN THE SWEDISH BRAIN TUMOUR REGISTRY 2018-2021 2023 ·Neuro-Oncology ·(unknown), (unknown), Björn Tavelin, Roger Henriksson	1
3	Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study 2022 ·Acta Oncologica ·Lena Wettergren, Lars E. Eriksson, (unknown), Christel Hedman, Johan Ahlgren, Karin E. Smedby, Kristina Hellman, Roger Henriksson, Claudia Lampic	12
4	Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model 2019 ·Scientific Reports ·Adrian Levitsky, Maria Pernemalm, Britt‐Marie Bernhardson, Jenny Forshed, Karl Kölbeck, Maria Olin, Roger Henriksson, Janne Lehtiö, Carol Tishelman, Lars E. Eriksson	19
5	PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status 2016 ·Oncotarget ·(unknown), Tamador Elsir, (unknown), Daniel Hägerstrand, Joseph W. Carlson, M Łysiak, Roger Henriksson, Fredrik Pontén, Johan Rosell, Peter Söderkvist, Roger Stupp, Elena Tchougounova, Monica Nistér, Annika Malmström, Anja Smits	11
6	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial 2015 ·Journal of Clinical Oncology ·Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy F. Cloughesy, Olivier Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, N. Moore, Samir Kharbanda, Franklin Peale, Priti S. Hegde, Lauren E. Abrey, Heidi Phillips, Carlos Bais	208
7	Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer 2014 ·Cancer Research ·Patricia A. Thompson, Ingrid Ljuslinder, Spyros Tsavachidis, Abenaa M. Brewster, Ayşegül A. Şahin, Håkan Hedman, Roger Henriksson, Melissa L. Bondy, Beatrice Melin	27
8	[Free of charge mammography gets more people to the examination. Study in Stockholm County shows good efficacy in socioeconomically disadvantaged areas]. 2014 ·PubMed ·Sven Törnberg, Elisabet Lidbrink, Roger Henriksson	8
9	HEALTH-RELATED QUALITY OF LIFE (HRQOL) ANALYSES IN THE AVAGLIO STUDY, A RANDOMIZED, PLACEBO-CONTROLLED PHASE III TRIAL OF BEVACIZUMAB, TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA 2013 ·Neuro-Oncology ·Martin Klein, Roger Henriksson, Andrew Bottomley, Timothy F. Cloughesy, Wolfgang Wick, Warren Mason, Frank Saran, Ryo Nishikawa, Arliene Ravelo, Magalie Hilton, Olivier Chinot	4
10	FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA 2013 ·Neuro-Oncology ·Olivier Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Alain Carpentier, Khê Hoang‐Xuan, Petr Kavan, Dana Cernea, Alba A. Brandes, Magalie Hilton, Yannick Kerloëguen, (unknown), (unknown)	3
11	Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity 2011 ·Acta Oncologica ·Xuping Wu, Håkan Hedman, Michael Bergqvist, Stefan Bergström, Roger Henriksson, Joachim Gullbo, Johan Lennartsson, Patrik Hesselius, Simon Ekman	17
12	Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker 2008 ·Carcinogenesis ·(unknown), Haixin Lei, Andreas Brandt, Robert Johansson, Kerstin Enquist, Roger Henriksson, Kari Hemminki, Per Lenner, Asta Försti	129
13	Heterogeneity in the expression of markers for drug resistance in brain tumors. 2004 ·PubMed ·Ulrika Andersson, Beatrice Malmer, (unknown), Thomas Brännström, Roger Henriksson	37
14	The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model 2004 ·British Journal of Cancer ·Maria Sandström, Mattias Johansson, Ulrika Andersson, Anders Bergh, A. Tommy Bergenheim, Roger Henriksson	38
15	Effects of IL-2 treatment on different compartments of the irradiated rat lung analysed by bronchoalveolar lavage and lung tissue morphology 1995 ·European Respiratory Journal ·(unknown), L Bjermer, (unknown), O Nettelbladt, Alex Karlsson‐Parra, Roger Henriksson	1
16	Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. 1994 ·PubMed ·A. Tommy Bergenheim, P. Björk, Jonas Bergh, E. von Schoultz, (unknown), Roger Henriksson	19
17	Fractionated Irradiation and Late Changes in Rat Parotid Gland: Effects on the Number of Acinar Cells, Potassium Efflux, and Amylase Secretion 1993 ·International Journal of Radiation Biology ·Lars Franzén, H. Gustafsson, (unknown), Mikael Karlsson, B. Littbrand, Roger Henriksson	22
18	Radiation-induced increase in hyaluronan and fibronectin in bronchoalveolar lavage fluid from breast cancer patients is suppressed by smoking 1992 ·European Respiratory Journal ·Leif Bjermer, Roger Hällgren, Kenneth Nilsson, Lars Franzén, Thomas Sandström, Bengt Särnstrand, Roger Henriksson	18
19	Secretory behavior and ultrastructural changes in mouse gallbladder principal cells after stimulation with cholinergic and adrenergic drugs 1979 ·Gastroenterology ·Hans Axelsson, Åke Danielsson, Roger Henriksson, Torkel Wahlin	4
20	Quantitative structural analysis and the secretory behaviour of the rat parotid gland after long and short term isoprenaline treatment. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Bengt Carlsöö, Anna Danielsson, H. Gustafsson, Roger Henriksson	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact